Drugs / PF-05206388
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01691261 | Oct 2021 → Oct 2023 | wet macular degeneration | Moorfields Eye Hospital NHS Foundation Trust | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PF-05206388 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01691261 ↗ |
| Modality | Cell therapy | “human embryonic stem cell derived retinal pigment epithelium (rpe) living tissue equivalent” NCT01691261 ↗ |
| Route | Other | “for intraocular use” NCT01691261 ↗ |